Fresenius says to buy Kyorin blood business

FRANKFURT, April 25 (Reuters) - Germany's Fresenius (FREG_p.DE) said on Wednesday it would buy the blood volume replacement business of Japanese pharmaceutical company Kyorin Pharmaceutical Co 4560.T for an undisclosed price.

Fresenius said in a statement that Kyorin's artificial colloids sales were 5.2 million euros ($7 million) in the fiscal year ending March 2006.

The colloids are mainly used in surgical and emergency procedures to substitute blood loss.

((Reporting by Rajiv Sekhri, Frankfurt Newsroom, Reuters Messaging rm:/rajiv.sekhri.reuters.com@reuters.net +49 69 7565 1244, rajiv.sekhri@reuters.com))

($1=.7373 Euro)

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nFAB012920